Miami Neuroscience Center Successfully Migrates from Legacy Cobalt-Based Technology to Modern Vault-Free, Cobalt-Free Cranial Radiosurgery Delivery
SAN CARLOS, Calif.–(BUSINESS WIRE)–ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced that the Miami Neuroscience Center at Larkin Community Hospital has fully transitioned its stereotactic radiosurgery (SRS) program from earlier-generation cobalt-60 (Co-60)–based technology to the modern ZAP-X® Gyroscopic Radiosurgery® platform. Since December 2025, all cranial radiosurgery procedures at the center are now performed using the next-generation ZAP-X system.
The transition represents a significant technological milestone for one of the most experienced radiosurgery programs in the United States. Under the leadership of Aizik L. Wolf, MD, FACS, Medical Director of the Miami Neuroscience Center, the program has delivered more than 15,000 stereotactic radiosurgery treatments over the past three decades using earlier-generation Co-60 systems.
Dr. Wolf is internationally recognized as a leading authority in stereotactic radiosurgery. With more than 35 years of neurosurgical experience, he has authored over 100 scientific publications, lectured extensively around the world, and helped pioneer radiosurgery adoption in the United States. Notably, Dr. Wolf was the first physician to introduce Co-60 radiosurgery to the state of Florida and performed the nation’s first outpatient Co-60 stereotactic radiosurgery procedure.
Today, the Miami Neuroscience Center serves as a regional SRS center of excellence, treating patients not only from Florida and the Southeastern United States but also from Central and South America.
“The transition to ZAP-X represents the natural evolution of radiosurgery,” said Dr. Aizik Wolf. “After delivering thousands of treatments with earlier cobalt-based technology, it is clear that modern radiosurgery programs must embrace systems that eliminate radioactive sources while maintaining the precision and clinical performance that define modern stereotactic radiosurgery.”
The center maintains a highly active clinical program treating both oncologic and functional neurological conditions. In addition to radiosurgical management of primary brain tumors and secondary metastases, the team performs an even higher volume of functional radiosurgery procedures, including treatments for trigeminal neuralgia and thalamotomy for tremor.
Dr. Wolf and his clinical team have also played an important role in the development of new technologies designed to enhance treatment delivery on the ZAP-X platform. The Miami group contributed to the development of the recently introduced PinZ® Patient Immobilizer*, an optional immobilization solution designed for patients who require additional stabilization during treatment.
“The PinZ immobilizer addresses an important clinical need,” Dr. Wolf added. “While most patients do extremely well with mask-based immobilization, some individuals, such as those with Parkinson’s or tremors, require additional stability to safely deliver the highest-precision treatments. This system provides clinicians with a valuable supplemental option for managing those challenging cases.”
The ZAP-X Gyroscopic Radiosurgery platform represents a modern rethinking of dedicated cranial radiosurgery technology. Unlike legacy cobalt-based systems, ZAP-X eliminates the need for costly shielded radiation bunkers and radioactive sources while incorporating advanced gyroscopic beam delivery designed specifically for intracranial treatments.
With its transition now complete, the Miami Neuroscience Center continues its long tradition of innovation in radiosurgery – advancing the field while expanding access to state-of-the-art care for patients across the Americas.
* The PinZ Patient Immobilizer is currently U.S. FDA cleared, and pending clearance in other regions.
About ZAP Surgical Systems, Inc.
ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, is committed to reducing the costs and complexities that limit access to world-class radiosurgery (SRS) for the brain, head, and neck. The company manufactures the ZAP-X® Gyroscopic Radiosurgery® platform and is also pioneering new applications of high-precision SRS in areas such as depression, addiction, and obesity. Founded in 2014 by Dr. John R. Adler, Emeritus Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology at Stanford University, ZAP introduced the world’s first vault-free radiosurgery platform – eliminating the need for costly shielded treatment rooms and enabling flexible, high-visibility siting. ZAP-X also advances beyond legacy Cobalt-60 technology with a modern linear accelerator for safer, more sustainable care. Learn more at ZAP Surgical and follow us on LinkedIn.
Contacts
Mark Arnold
Executive Vice President, Marketing
Email: [email protected]
Nikita Kulkarni
Chief Financial Officer / Investor Relations
Email: [email protected]
